| CAS NO: | 1655501-53-3 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 生物活性 | Fremanezumab (TEV-48125) is a humanizedIgG2amonoclonal antibody that selectively and potently binds tocalcitoningene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research[1]. |
| Clinical Trial | |
| 性状 | Liquid |
| CAS 号 | 1655501-53-3 |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com